NovoCure (N2VC34.SA) Q4 2024 Earnings

Oct 30Confirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-2.59
-2.26
-1.94
-1.61

Details

Expected EPS
-1.9234557399999999
Actual EPS
-1.613444
Surprise EPS
0.31
Surprise Percent
+16.12%

Description

⁨NovoCure⁩ (⁦N2VC34.SA⁩) has reported earnings of ⁦-1.613444⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts